SOURCE: Endo Pharmaceuticals

April 24, 2008 17:06 ET

Endo Pharmaceuticals to Hold Conference Call on First Quarter 2008 Financial Results

CHADDS FORD, PA--(Marketwire - April 24, 2008) - Endo Pharmaceuticals Holdings Inc. (NASDAQ: ENDP), a market leader in pain management, will announce its financial results for the first quarter ended March 31, 2008 before the market opens on April 30, 2008, and will hold a conference call at 11:00 a.m. ET that day to discuss these results.

David P. Holveck, President and Chief Executive Officer, Nancy J. Wysenski, Chief Operating Officer and Charles A. Rowland, Jr., Chief Financial Officer will host the call.

Investors and other interested parties may access the conference call as follows:

Telephone Numbers

(888) 679-8037 (domestic), (617) 213-4849 (international)

Passcode: 14308221

Please dial in 10 minutes prior to the scheduled start time.


A replay of the call will be available from April 30, 2008 at 1:00 p.m. ET by dialing (888) 286-8010 (domestic) or (617) 801-6888 (international), passcode 86185475, and will run until 12:00 a.m. ET on May 7, 2008.


A simultaneous webcast of the call for interested investors and others may be accessed by visiting In addition, a replay of the webcast will be available until 12:00 a.m. ET on May 7, 2008. The replay can be accessed by clicking on "Events" in the Investor Relations section of the website.

About Endo

Endo Pharmaceuticals Holdings Inc. is a fully integrated specialty pharmaceutical company with market leadership in pain management products. Through its Endo Pharmaceuticals Inc. subsidiary, the company researches, develops, produces and markets a broad product offering of branded and generic pharmaceuticals, meeting the needs of healthcare professionals and consumers alike. More information, including this and past press releases of Endo Pharmaceuticals Holdings Inc., is available online at